26^th Global Ophthalmologists Annual Meeting

Welcome Message

Welcome to the 26th Global Ophthalmologists Annual Meeting!
January 12-13, 2026 | London, UK

We are thrilled to have you join us for this prestigious event, where leading ophthalmologists, researchers, and innovators from around the world come together to share knowledge, explore new developments, and discuss the future of eye care. This year, we are proud to host the meeting in London, a city renowned for its rich history, cutting-edge medical advancements, and vibrant academic community.

Over the next two days, we will explore the latest in ophthalmology, from pioneering research to breakthrough technologies, and discuss the most pressing issues facing the field today. We encourage you to engage, collaborate, and network with your peers to advance our collective goal of improving vision care for patients globally.

Thank you for being part of this important event. We look forward to the exciting discussions, collaborations, and insights that will shape the future of ophthalmology.

Enjoy the meeting, and let’s make this a memorable and impactful experience for all!

Warm regards,
The Organizing Committee
26th Global Ophthalmologists Annual Meeting
January 12-13, 2026 London, UK 

About Conference

The 26th Global Ophthalmologists Annual Meeting is a premier international event bringing together ophthalmologists, clinicians, researchers, educators, and industry leaders from around the globe to explore the latest advancements in the field of eye care. Held in the historic and vibrant city of London, UK, this two-day conference offers an exceptional opportunity for knowledge exchange, networking, and collaboration.

This year's meeting will feature:

• Keynote Speeches from world-renowned experts in ophthalmology, focusing on cutting-edge research, emerging technologies, and innovative treatment modalities.
• Scientific Sessions covering a wide range of topics including retinal diseases, glaucoma, cataract surgery, corneal health, pediatric ophthalmology, and advances in ocular pharmacology.
• Workshops and Live Demonstrations where attendees can experience hands-on learning in the latest surgical techniques and diagnostic tools.
• Interactive Panels and case discussions aimed at tackling real-world challenges faced by ophthalmologists in clinical practice.
• Industry Exhibitions showcasing the latest products, technologies, and services available to the ophthalmology community.

This conference serves as a platform for advancing the global conversation on the future of eye health, fostering collaboration between academia, clinical practice, and the medical industry. Whether you’re looking to stay updated on the latest research, enhance your clinical skills, or forge new professional relationships, the 26th Global Ophthalmologists Annual Meeting promises to be a memorable and impactful experience.

We welcome participants from all levels of expertise to join us in shaping the future of ophthalmology and improving patient care worldwide.

Who Should Attend?

The Ophthalmology Conference 2026 is designed for professionals and stakeholders in the field of eye care. It’s ideal for anyone involved in the diagnosis, treatment, research, or management of eye diseases and vision health. Key attendees should include:

• Ophthalmologists & Eye Specialists: Those specializing in eye care, including general ophthalmologists and subspecialists (e.g., retina, cornea, glaucoma).
• Optometrists & Opticians: Professionals focused on vision testing, corrective lenses, and monitoring eye health.
• Ophthalmology Residents & Fellows: Trainees specializing in ophthalmology who want to enhance their expertise and connect with leading experts.
• Researchers & Academics: Scientists and scholars advancing ophthalmic research and looking to collaborate on new discoveries.
• Medical Students: Students with an interest in ophthalmology, eager to learn about advancements in eye health.
• Healthcare Professionals: Nurses, technicians, and other staff working in ophthalmology clinics or assisting with patient care.
• Pharmaceutical & Medical Device Representatives: Those working in the development of eye care drugs, surgical tools, and diagnostic technologies.
• Policy Makers & Public Health Officials: Individuals involved in healthcare policy and public health initiatives related to vision health.
• Patient Advocacy Groups: Organizations representing individuals with vision impairments or eye diseases, seeking to stay informed on the latest treatments.
• General Practitioners & Family Physicians: Doctors who want to expand their knowledge of eye health and improve their care for patients with vision concerns.

For Registration
For Abstract Submission

Target Audience

• Ophthalmologists
• Eye Specialists
• Optometrists
• Opticians
• Ophthalmology Residents
• Ophthalmology Fellows
• Medical Researchers
• Academics in Ophthalmology
• Medical Students
• Ophthalmic Nurses
• Ophthalmic Technicians
• Healthcare Providers in Eye Care
• Pharmaceutical Companies
• Medical Device Companies
• Biotechnology Firms in Ophthalmology
• Healthcare Administrators
• Policy Makers in Eye Health
• Public Health Officials
• Patient Advocacy Groups
• Non-Profit Organizations Focused on Vision Health
• General Practitioners (GPs)
• Family Physicians
• Surgical Ophthalmologists
• Retina Specialists
• Cornea Specialists

Sessions and Tracks

Track 01. Advances in Cataract Surgery

Cataract surgery is one of the most frequently performed procedures in ophthalmology, restoring vision and improving quality of life for millions globally. Modern cataract surgery focuses on precision, safety, and optimal visual outcomes. Phacoemulsification remains the standard technique, using ultrasonic energy to remove the lens through a small incision. Recent advancements, such as femtosecond laser-assisted surgery, allow automated lens fragmentation, capsulotomy, and corneal incisions, increasing surgical accuracy and reducing complications. Intraocular lens technology has evolved significantly, with multifocal, toric, and extended depth of focus lenses offering correction of pre-existing refractive errors alongside cataract removal. Preoperative imaging and biometry enable personalized surgical planning, ensuring proper lens placement and alignment. Minimally invasive techniques reduce recovery time, postoperative astigmatism, and complication rates. Perioperative care, including evaluation of systemic conditions and careful postoperative management, is essential for successful outcomes. Future developments in cataract surgery involve artificial intelligence, robotics, and potential regenerative therapies, promising further precision and personalized patient care. Surgeons and researchers continue to advance techniques and technologies, enhancing visual restoration and patient satisfaction, making cataract surgery a continually evolving and critical area of ophthalmology.

Track 02. Innovations in Refractive Surgery

Refractive surgery has transformed vision correction, offering alternatives to glasses and contact lenses for myopia, hyperopia, and astigmatism. Techniques such as LASIK, PRK, and SMILE have improved safety, precision, and recovery times due to advancements in laser technology and corneal mapping. Detailed preoperative assessment ensures personalized treatment plans tailored to individual corneal anatomy and refractive needs. Minimally invasive procedures, including small-incision and flapless surgeries, reduce recovery time and postoperative complications. Phakic intraocular lenses provide solutions for complex refractive errors where corneal procedures are not feasible. Surgical planning software and eye-tracking systems enhance accuracy and outcomes, while research continues to improve higher-order aberration correction and night vision quality. Refractive surgery represents a dynamic field where technology, precision, and patient-centered care converge. Ongoing innovations aim to provide safer, more effective, and predictable results, improving visual function and overall quality of life for patients worldwide.

Track 03. Glaucoma: Diagnosis and Management

Glaucoma is a leading cause of irreversible blindness globally, making early detection essential. Advances in imaging technologies such as optical coherence tomography allow precise evaluation of the optic nerve and retinal nerve fiber layer, facilitating early diagnosis and monitoring of disease progression. Medical therapy remains the first-line treatment, while laser procedures like selective laser trabeculoplasty and micro-pulsed techniques offer minimally invasive alternatives. Surgical interventions, including trabeculectomy and minimally invasive glaucoma surgeries, provide long-term pressure control with fewer complications. Effective glaucoma care involves patient education, adherence monitoring, and regular follow-up. Research into neuroprotection, drug delivery systems, and genetic factors is ongoing. Comprehensive management combining clinical expertise, technology, and patient engagement is essential to preserve vision and quality of life.

Track 04. Retinal Disorders: Treatment and Research

Retinal disorders such as age-related macular degeneration, diabetic retinopathy, and retinal vascular diseases are major causes of vision loss. Early diagnosis and intervention are crucial for preserving vision. Imaging techniques including optical coherence tomography, fundus photography, and angiography allow detailed visualization of retinal structures. Medical therapies such as intravitreal injections and corticosteroids, along with surgical procedures like vitrectomy, have improved patient outcomes. Research into regenerative therapies, gene therapy, and stem cell interventions aims to restore retinal function and prevent disease progression. Screening programs and multidisciplinary care improve long-term outcomes for patients with chronic retinal diseases. Ongoing innovations continue to enhance both treatment effectiveness and quality of life for affected individuals worldwide.

Track 05. Corneal Diseases and Transplantation

Corneal diseases are a leading cause of visual impairment, and recent advances in keratoplasty techniques have significantly improved outcomes. Procedures such as penetrating, lamellar, and endothelial keratoplasty restore corneal transparency while minimizing complications. Femtosecond laser-assisted surgery increases precision, improving graft fit and recovery time. Tissue engineering, stem cell therapy, and artificial corneas offer new solutions for advanced corneal disorders. Minimally invasive approaches preserve healthy tissue while providing excellent visual outcomes. Successful management requires careful preoperative evaluation, postoperative monitoring, and treatment of associated conditions. Research continues to explore novel therapies, immunomodulation, and regenerative medicine to enhance graft survival and patient outcomes. Corneal care demonstrates the integration of innovation, surgical skill, and patient-focused strategies to restore vision and improve quality of life.

Track 06. Pediatric Ophthalmology and Strabismus

Pediatric ophthalmology focuses on diagnosing and managing eye disorders in children, including strabismus, amblyopia, congenital cataracts, and other developmental visual conditions. Early detection and intervention are critical for preventing lifelong visual impairment. Advances in imaging, visual function assessment, and screening programs enable timely identification of ocular abnormalities in children. Strabismus management involves both non-surgical and surgical strategies to correct misalignment and restore binocular vision. Therapies such as patching, vision therapy, and prism correction are used in combination with surgical techniques when necessary. Pediatric cataract surgery requires specialized approaches due to smaller anatomical structures and the need to consider long-term ocular growth. Recent research emphasizes genetic evaluation, personalized care plans, and early rehabilitation to optimize visual outcomes. Multidisciplinary care involving pediatricians, orthoptists, and ophthalmologists improves patient monitoring and long-term development. Pediatric ophthalmology integrates advanced diagnostics, surgical expertise, and early intervention strategies to ensure that children achieve optimal visual development and quality of life.

Track 07. Neuro-Ophthalmology: Clinical Insights

Neuro-ophthalmology examines the interface between the visual system and the nervous system, focusing on conditions such as optic neuropathies, visual pathway disorders, cranial nerve palsies, and neuro-ophthalmic manifestations of systemic diseases. Accurate diagnosis requires a combination of neurological and ophthalmic assessment, supported by advanced imaging techniques like MRI and optical coherence tomography. Management strategies vary depending on the underlying cause and may include medical therapy, surgical intervention, or systemic treatment for associated neurological disorders. Emerging technologies enhance diagnostic precision and aid in monitoring disease progression. Research in neuro-ophthalmology explores genetic causes, neuroprotective strategies, and the role of imaging biomarkers in predicting outcomes. Clinicians must integrate multidisciplinary knowledge from neurology, ophthalmology, and neuroimaging to deliver effective, patient-centered care. Neuro-ophthalmology is essential for preserving vision and understanding complex interactions between ocular and neurological health.

Track 08. Ocular Surface Disorders and Dry Eye

Ocular surface disorders, including dry eye disease, keratoconjunctivitis sicca, and ocular surface inflammation, significantly affect vision and quality of life. Diagnosis relies on clinical evaluation, tear film analysis, and imaging techniques to assess corneal and conjunctival health. Management strategies include artificial tears, anti-inflammatory therapy, punctal plugs, and lifestyle modifications. Recent research highlights novel pharmacological treatments, regenerative therapies, and devices to improve tear film stability and ocular surface integrity. Early detection and personalized treatment plans are critical for preventing complications and long-term vision impairment. Ocular surface care integrates advanced diagnostics, innovative therapies, and patient education to enhance visual comfort and quality of life. Continuous research in this field contributes to improved outcomes and novel approaches for managing chronic ocular surface diseases.

Track 09. Uveitis and Ocular Immunology

Uveitis represents a group of inflammatory eye disorders that can lead to vision loss if untreated. Advances in diagnosis, including imaging and laboratory testing, help identify the underlying causes, whether autoimmune, infectious, or idiopathic. Management involves corticosteroids, immunosuppressive therapies, and biologics tailored to the disease type and severity. Emerging therapies focus on targeted immune modulation to reduce side effects while effectively controlling inflammation. Close monitoring and multidisciplinary care are essential to prevent complications such as glaucoma, cataract, or retinal damage. Research in ocular immunology explores the mechanisms of inflammation, novel therapeutic targets, and the role of systemic diseases in ocular pathology. Effective uveitis management combines clinical expertise, advanced diagnostics, and personalized treatment plans to preserve vision and improve patient outcomes.

Track 10. Ophthalmic Oncology: Diagnosis and Therapy

Ophthalmic oncology addresses tumors of the eye and adnexa, including retinoblastoma, ocular melanoma, conjunctival tumors, and orbital malignancies. Early diagnosis is critical for preserving vision and preventing metastasis. Advanced imaging modalities such as ultrasonography, MRI, and fundus photography enable precise assessment of tumor size, location, and progression. Treatment strategies include surgery, radiotherapy, chemotherapy, and targeted therapies. Multidisciplinary care involving ophthalmologists, oncologists, and radiologists ensures optimal outcomes and reduces recurrence risk. Emerging therapies, including immunotherapy and gene-based approaches, are expanding treatment options and improving survival rates. Research focuses on understanding tumor biology, improving early detection, and developing less invasive therapeutic techniques. Ophthalmic oncology integrates clinical expertise, advanced diagnostics, and innovative treatment strategies to protect vision and enhance patient prognosis.

Track 11. Ocular Imaging Technologies

Ocular imaging technologies have revolutionized the diagnosis and management of eye diseases. Tools such as optical coherence tomography, fundus photography, fluorescein angiography, and confocal microscopy allow detailed visualization of retinal, corneal, and optic nerve structures. These technologies enable early detection of subtle pathological changes that may not be visible with conventional examination techniques. Advancements in imaging software provide quantitative analysis, three-dimensional reconstruction, and automated measurement of ocular structures. Such innovations enhance diagnostic accuracy, allow precise monitoring of disease progression, and support surgical planning. Imaging also plays a key role in research, aiding in the understanding of disease mechanisms and treatment responses. The integration of artificial intelligence into ocular imaging is an emerging trend, providing automated detection of diabetic retinopathy, glaucoma, and macular degeneration with high sensitivity and specificity. Ocular imaging technologies are now essential for modern ophthalmology, improving clinical outcomes and guiding personalized patient care. Continuous advancements promise to further enhance visualization, diagnostic precision, and patient management strategies.

Track 12. Precision Ophthalmology: Genomics and Personalized Medicine

Precision ophthalmology applies genomic information and individualized approaches to diagnose and treat eye diseases. Genetic analysis identifies mutations responsible for inherited retinal disorders, glaucoma, and corneal dystrophies, allowing early intervention and tailored therapies. Personalized medicine aims to optimize treatment efficacy while minimizing adverse effects. Advances in molecular diagnostics, gene therapy, and pharmacogenomics enable ophthalmologists to deliver targeted interventions. For example, specific gene therapies can restore retinal function in inherited retinal diseases, and pharmacogenomic profiling can guide the selection of anti-glaucoma medications. Integrating genomic data with imaging and clinical findings enhances patient-specific decision-making. This approach also supports predictive risk assessment, enabling proactive management of patients predisposed to ocular diseases. Ongoing research in genomics, regenerative medicine, and personalized pharmacology is expanding treatment possibilities and improving outcomes. Precision ophthalmology represents the future of individualized patient care, where genetic and molecular insights drive targeted, effective, and safer therapies.

Track 13. Artificial Intelligence in Eye Care

Artificial intelligence is transforming ophthalmology by enhancing diagnosis, treatment planning, and disease monitoring. AI algorithms analyze imaging data to detect conditions such as diabetic retinopathy, glaucoma, and age-related macular degeneration with high accuracy. These technologies reduce diagnostic errors, streamline workflows, and facilitate early intervention. Machine learning models can predict disease progression, identify high-risk patients, and recommend personalized treatment strategies. AI-powered teleophthalmology platforms expand access to eye care, particularly in remote or underserved regions, enabling real-time screening and consultation. Research continues to integrate AI with electronic health records, wearable devices, and multimodal imaging for comprehensive patient assessment. While AI does not replace clinical expertise, it enhances decision-making and efficiency, providing ophthalmologists with powerful tools to improve patient outcomes. AI is increasingly a cornerstone of modern ophthalmology, driving innovation and precision in eye care.

Track 14. Minimally Invasive Ophthalmic Surgery

Minimally invasive ophthalmic surgery focuses on reducing surgical trauma while achieving optimal outcomes. Techniques such as microincision cataract surgery, sutureless glaucoma procedures, and small-gauge vitrectomy reduce recovery time, minimize complications, and improve patient comfort. Advanced surgical instruments, improved visualization, and refined fluidics systems enhance precision and efficiency. Minimally invasive approaches are particularly valuable in complex cases, including coexisting ocular conditions or high-risk patients. Surgeons can achieve excellent visual outcomes while preserving surrounding tissues and reducing postoperative inflammation. Emerging technologies and robotic assistance further refine these procedures, allowing greater accuracy and reproducibility. Minimally invasive surgery represents a patient-centered evolution in ophthalmology, emphasizing safety, rapid recovery, and high-quality visual results while maintaining clinical efficacy.

Track 15. Advances in Optometry and Vision Science

Optometry and vision science are evolving rapidly, driven by research, technological innovations, and evidence-based practice. Modern optometric care includes comprehensive eye examinations, early detection of ocular diseases, and management of refractive errors. Advances in diagnostic devices and imaging allow detailed assessment of ocular structures and visual function. Research in visual neuroscience, binocular vision, and ocular physiology informs clinical practice, guiding treatment for conditions such as amblyopia, strabismus, and visual fatigue. Contact lens technology, low vision rehabilitation, and vision therapy programs continue to improve patient quality of life. Integration of optometry with multidisciplinary ophthalmic care ensures holistic management of eye health, emphasizing prevention, early intervention, and personalized strategies. Ongoing developments in vision science provide tools and knowledge to enhance diagnostic accuracy, treatment effectiveness, and overall eye care delivery worldwide.

Track 16. Eye Care in Aging Population

Age-related eye conditions are a major cause of vision impairment and blindness worldwide. Common disorders include cataracts, glaucoma, macular degeneration, and diabetic retinopathy. Early detection and timely intervention are crucial to preserve vision and maintain quality of life in elderly patients. Advances in diagnostic imaging, surgical techniques, and medical therapy allow effective management of age-related eye diseases. Cataract surgery with modern intraocular lenses can restore clear vision, while minimally invasive glaucoma procedures help control intraocular pressure safely. Nutritional supplements, lifestyle modifications, and regular monitoring contribute to the prevention and progression of retinal diseases. Multidisciplinary approaches involving ophthalmologists, optometrists, primary care physicians, and geriatric specialists ensure comprehensive care. Patient education on eye health, adherence to treatment, and regular screening programs are essential for optimal outcomes. Focusing on the aging population highlights the need for tailored strategies to address unique challenges, improve vision care, and enhance overall well-being for older adults.

Track 17. Myopia and Refractive Error Management

Myopia and other refractive errors are increasingly prevalent worldwide, particularly among children and adolescents. Uncontrolled progression can lead to high myopia and associated complications such as retinal detachment and glaucoma. Early identification and management are essential to reduce long-term visual risk. Modern strategies include optical interventions such as orthokeratology, multifocal lenses, and specialized contact lenses, alongside pharmaceutical treatments like low-dose atropine. Lifestyle modifications, including outdoor activity and screen time reduction, play an important preventive role. Advanced diagnostic tools enable precise assessment of refractive errors, corneal shape, and axial length to guide individualized treatment plans. Research focuses on understanding genetic and environmental factors driving myopia progression. Collaborative efforts between clinicians, educators, and families are critical for implementing effective management strategies. Addressing myopia and refractive errors improves vision outcomes and prevents future complications, particularly in younger populations.

Track 18. Diabetic Retinopathy: Prevention and Treatment

Diabetic retinopathy is a leading cause of preventable blindness in adults, resulting from microvascular damage caused by diabetes. Early detection through regular retinal screening is essential for preventing vision loss. Imaging technologies such as optical coherence tomography and fundus photography allow detailed assessment of retinal changes.Treatment includes medical management of diabetes, intravitreal injections of anti-vascular endothelial growth factor agents, and laser photocoagulation. Surgical intervention may be necessary in advanced cases such as proliferative diabetic retinopathy or vitreous hemorrhage. Preventive strategies, patient education, and tight glycemic control play a significant role in reducing the incidence and progression of this condition. Ongoing research explores regenerative therapies, novel pharmacological approaches, and telemedicine-based screening programs to enhance care accessibility. Comprehensive management combining systemic control, early detection, and advanced treatment modalities is essential to preserve vision and quality of life for patients with diabetes.

Track 19. Ophthalmic Pharmaceuticals and Drug Development

Pharmaceutical advancements in ophthalmology have expanded treatment options for a wide range of eye diseases, including glaucoma, retinal disorders, and ocular surface diseases. Novel drug delivery systems, such as sustained-release implants, topical nanocarriers, and injectable therapies, enhance efficacy and reduce systemic side effects. Research in drug development focuses on targeted therapies, biologics, and immunomodulatory agents. Anti-vascular endothelial growth factor therapies have revolutionized retinal disease management, while newer pharmacological agents provide improved control of inflammation, infection, and intraocular pressure. Clinical trials continue to explore innovative molecules and delivery methods to optimize patient outcomes. Effective ophthalmic pharmacotherapy requires careful selection based on disease severity, ocular anatomy, and patient-specific factors. Integration of pharmaceuticals with advanced surgical and diagnostic techniques ensures comprehensive management of ocular conditions. Continued innovation in ophthalmic drug development promises safer, more effective, and accessible treatments for patients worldwide.

Track 20. Corneal and Contact Lens Innovations

Corneal health and vision correction have benefited from significant innovations in contact lens technology and therapeutic interventions. Modern lenses address refractive errors, keratoconus, post-surgical corneal irregularities, and dry eye, improving vision and ocular surface comfort. Advances include scleral lenses, hybrid designs, and customized lens fitting using precise corneal topography and wavefront analysis. Corneal interventions, including minimally invasive surgery and regenerative therapies, enhance outcomes for patients with corneal diseases or injuries. Emerging drug delivery systems through contact lenses are being developed to provide sustained therapeutic effects. Patient-centered care involves careful evaluation, personalized lens selection, and ongoing monitoring to optimize outcomes and prevent complications. Innovations in corneal and contact lens technologies continue to expand treatment possibilities, improve visual function, and enhance quality of life for patients with corneal disorders or refractive needs.

Track 21. Oculoplastics and Orbital Surgery

Oculoplastics focuses on the reconstruction and cosmetic improvement of eyelids, orbit, and lacrimal system. Conditions such as ptosis, eyelid malpositions, orbital fractures, tumors, and tear duct obstructions are commonly addressed in this subspecialty. Surgical interventions aim to restore function, protect the eye, and improve appearance. Advances in imaging, microsurgical techniques, and minimally invasive procedures allow precise diagnosis and effective treatment planning. Endoscopic approaches and implantable devices enhance outcomes for lacrimal and orbital surgeries. Multidisciplinary collaboration with dermatology, oncology, and neurosurgery improves complex case management. Oculoplastic care emphasizes both functional restoration and aesthetic outcomes. Personalized surgical planning, careful patient evaluation, and postoperative monitoring are critical for success. Innovations continue to expand treatment possibilities, reduce complications, and enhance patient satisfaction in both reconstructive and cosmetic ophthalmic surgery.

Track 22. Retinopathy of Prematurity

Retinopathy of prematurity is a potentially blinding condition affecting premature infants due to abnormal retinal vascular development. Early detection and intervention are essential to prevent lifelong vision impairment. Screening programs using advanced imaging allow timely diagnosis and risk stratification. Treatment options include laser photocoagulation, anti-vascular endothelial growth factor therapy, and surgical intervention in advanced stages. Multidisciplinary care involving neonatologists, ophthalmologists, and nurses ensures comprehensive monitoring and management. Research focuses on understanding risk factors, improving screening protocols, and developing novel therapies to prevent progression. Effective management combines early identification, prompt treatment, and follow-up, safeguarding vision in vulnerable pediatric populations.

Track 23. Eye Trauma and Emergency Care

Eye trauma can lead to significant vision loss if not promptly and properly managed. Causes range from occupational injuries and accidents to sports-related trauma. Early assessment and intervention are crucial to preserve ocular structure and function. Advances in diagnostic imaging, surgical techniques, and microsurgical instruments have improved outcomes in complex ocular injuries. Procedures include corneal and scleral repair, intraocular foreign body removal, and retinal detachment management. Emergency protocols, multidisciplinary care, and patient education are essential components of trauma management. Ongoing research explores novel surgical materials, regenerative therapies, and telemedicine for rapid diagnosis and treatment. Comprehensive emergency eye care ensures timely intervention, minimizes complications, and improves functional and visual recovery for patients with ocular trauma.

Track 24. Teleophthalmology and Remote Eye Care

Teleophthalmology leverages technology to provide remote eye care services, including screening, diagnosis, and consultation. It is particularly valuable for underserved or rural populations where access to ophthalmologists is limited. Digital imaging, video consultations, and AI-assisted screening tools enhance diagnostic accuracy and patient management. Applications include diabetic retinopathy screening, glaucoma monitoring, postoperative follow-up, and patient education. Teleophthalmology improves healthcare accessibility, reduces travel burden, and allows early detection of ocular conditions. Integration of secure digital platforms, electronic health records, and AI-driven analytics supports effective remote monitoring and personalized care. Teleophthalmology represents a modern approach to expanding access to high-quality eye care worldwide.

Track 25. Global Trends in Eye Care and Public Health

Global eye health initiatives aim to reduce preventable blindness and improve vision care worldwide. Major efforts focus on early detection, accessibility of treatments, and public education regarding eye diseases. Conditions such as cataracts, refractive errors, glaucoma, and diabetic retinopathy are priority areas. International programs collaborate with governments, non-governmental organizations, and healthcare providers to implement screening, vaccination, and awareness campaigns. Technological innovations, including portable diagnostic devices and telemedicine, facilitate large-scale eye care delivery. Research into epidemiology, health systems, and cost-effective interventions informs policy and resource allocation. Addressing global trends in eye care ensures equitable access, prevention of vision loss, and improved quality of life for populations worldwide.

Abstract Review Process

Submission and Initial Review

Authors are invited to submit their abstracts through the official conference submission portal. https://annualmeeting.conferenceseries.com/ophthalmologists/abstract-submission.php

The abstract submission deadline is 10 December 2025. Each submitted abstract will undergo an initial review process, which typically takes 3–4 days. Authors will be notified of acceptance within 4 days of submission.

Guidelines for Abstract Submission:

• Abstracts must be submitted in English.
• Word limit: 250–300 words.
• Include title, author(s) name, affiliation, and contact details.
• Topics must align with ophthalmology, clinical practice, management, or innovation.
• Upload abstracts via the official submission portal or email to contact@speakermeeting.com

The Organizing Committee will evaluate all submissions based on relevance to the conference theme, originality, clarity, and scientific quality.

Acceptance and Notification

Following the review process, authors of accepted abstracts will receive an Abstract Acceptance Letter. To confirm participation, the presenting author must complete conference registration.

Registration Requirements:

• Each registration allows one individual to attend the conference.
• Co-authors wishing to attend must register and pay independently.
• Registered co-authors are eligible for a 15% discount on the Non-Presenter’s (Listener’s) Registration Fee.
• Registration Opens: July 05, 2025
• Early Bird Registration Closes: September 12, 2025
• Final Registration Deadline: January 12, 2026

Certification

Certificates of presentation will be issued only to co-authors who complete registration and payment.

Important Information for Co-Authors:

• Each co-author attending the conference must register and pay the applicable registration fee independently.
• To claim the co-author discount, prior communication with the Organizing Committee is required.
• Certificates will be provided only to registered co-authors.

For any questions or further assistance regarding abstract submission or registration, please contact the Organizing Committee.

Visa Process

Planning to attend the 26th Global Ophthalmologists Annual Meeting, taking place on January 12–13, 2026, in London, United Kingdom. Follow this detailed guide to navigate the visa application process smoothly.

Step 1: Complete Your Registration

Register for the 26th Global Ophthalmologists Annual Meeting. Once your registration is confirmed, you will receive an official invitation letter, which is essential for your visa application.

Step 2: Identify the Appropriate Visa

International delegates generally require a United Kingdom Standard Visitor visa. This visa allows stays of up to 6 months for attending conferences, business, or tourism purposes.

Step 3: Prepare Required Documents

Gather all necessary documents for your visa application, typically including:

• A valid passport with at least six months’ validity beyond your intended departure date
• Completed visa application form
• Official invitation letter from the 26th Global Ophthalmologists Annual Meeting
• Travel itinerary or flight reservations
• Proof of sufficient financial means, such as bank statements or proof of income
• Travel insurance covering medical expenses and repatriation for the entire duration of your stay

Step 4: Schedule a Visa Appointment

Contact the British embassy or consulate in your country to book an appointment. Early scheduling is recommended, especially during peak travel periods.

Step 5: Attend the Visa Interview

Attend your visa interview with all required documents. You may be asked about the purpose of your visit, your plans during the conference, and your ties to your home country to demonstrate your intent to return after the event.

Step 6: Wait for Visa Processing

UK visa processing typically takes 15 working days, though it may vary depending on the country. It is advisable to apply at least one month before your travel date to allow ample time for processing.

Step 7: Collect Your Visa

Once approved, you will be notified to collect your passport with the visa vignette. Verify all details and review any specific entry requirements.

Additional Tips

• Start the process early to avoid last-minute delays
• Ensure all documents are accurate and complete to prevent processing issues
• Confirm that your travel insurance meets UK requirements, including coverage for medical emergencies and repatriation

By following these steps, you can ensure a smooth and hassle-free visa application experience. Register today and prepare to join us in London, United Kingdom, for an enriching and informative gathering at the 26th Global Ophthalmologists Annual Meeting.

We look forward to welcoming you to London.

Market Analysis Report

The global ophthalmology market has experienced significant growth over the past decade, driven by rising prevalence of eye disorders, technological advancements in diagnostics and treatment, and an aging population. In 2024, the market was valued at approximately USD 77.10 billion, and it is projected to reach around USD 144.04 billion by 2034, reflecting a compound annual growth rate of 6.4%. Key segments include ophthalmic devices, pharmaceuticals, and surgical treatments. The expansion is fueled by increasing demand for advanced vision correction procedures, early detection of retinal and corneal diseases, and widespread adoption of minimally invasive surgical techniques.

The ophthalmology workforce has also grown globally, with over 232,000 practicing ophthalmologists worldwide. However, distribution remains uneven. High-income regions such as North America and Europe maintain a high density of ophthalmologists, while Africa, parts of Asia, and Latin America face critical shortages. These disparities directly influence market access, treatment outcomes, and patient care delivery. Teleophthalmology, artificial intelligence-assisted diagnostics, and mobile screening programs are emerging as solutions to bridge the gap between supply and demand.

Market Segmentation and Key Trends

The global ophthalmology market is segmented into devices, drugs, and surgical procedures:

Key market trends include:

• Adoption of artificial intelligence for automated retinal imaging and early disease detection.
• Growth of minimally invasive surgeries, improving patient recovery and outcomes.
• Increasing pharmaceutical innovation, including sustained-release implants and targeted therapies for retinal diseases.
• Expansion of telemedicine platforms, particularly in underserved regions, increasing access to routine eye care.

High demand for solutions addressing diabetic retinopathy, age-related macular degeneration, glaucoma, and cataracts is driving market expansion, alongside rising patient awareness and government health initiatives supporting eye care services.

By 2050, vision impairment is expected to double, with over 115 million people affected globally. Factors such as population growth, aging, and myopia prevalence are key contributors. High-demand regions like Europe and North America will continue to face pressure due to aging populations, while Africa and parts of Asia require significant investment in workforce development and infrastructure.

Emerging technologies, including gene therapies, regenerative medicine, robotic-assisted surgery, and AI-powered diagnostic tools, are expected to reshape the global ophthalmology market. Strategic investments in training, teleophthalmology, and digital health integration will be crucial to address future demand and reduce disparities in eye care access worldwide.

International & Regional Societies

Participants Benefits

• Networking Opportunities
• Access to Cutting-Edge Research
• Educational Sessions
• Abstract Presentation Opportunities
• Continuing Medical Education (CME) Points
• Continuing Professional Development (CPD) Points
• Exposure to Industry Innovations
• Certificate of Participation
• Interactive Workshops and Hands-On Training
• Opportunities for Collaboration
• Access to Conference Materials
• Career Advancement
• Discounts and Early Bird Offers

Past Conference Report

OPHTHALMOLOGY_2025

Welcome to the 25th Global Ophthalmologists Annual Meeting

Join us in beautiful Copenhagen, Denmark, for the 25th Global Ophthalmologists Annual Meeting on June 17-18, 2025. This milestone event brings together world-renowned experts, researchers, and professionals in ophthalmology to exchange knowledge, showcase innovations, and shape the future of eye care.

About the Meeting

The Global Ophthalmologists Annual Meeting is a premier event dedicated to advancing the field of ophthalmology through collaboration and innovation. Celebrating its 25th edition, this year’s meeting promises an exceptional lineup of keynote speakers, interactive sessions, and networking opportunities, all set against the vibrant backdrop of Copenhagen.